Latest Vertex Pharmaceuticals Inc. Stories
CF Foundation Provided Scientific, Clinical and Significant Funding Support in Drug Development Process BETHESDA, Md., June 24, 2014 /PRNewswire-USNewswire/ -- The Cystic Fibrosis
Editor Note: For more information about this release, please scroll to bottom. LONDON, March 26, 2014 /PRNewswire/ -- On Tuesday, March 25, 2014, the NASDAQ Composite
LONDON, January 16, 2014 /PRNewswire/ -- Editor Note: For more information about this release, please scroll to bottom. On Wednesday, January 15, 2014, the
BETHESDA, Md., June 10, 2011 /PRNewswire-USNewswire/ -- Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc's highly anticipated hepatitis C drug has finally won US approval, which will usher in a new marketing battle with a rival medicine from Merck & Co.
A meticulously watched hepatitis C drug, developed by Vertex Pharmaceuticals Inc, has a remarkable capability to stop the virus in patients in which other treatments were unsuccessful, and others not previously treated for the severe liver disease.